We are live on
!
Find out more
Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
AUM
$39.1B
1-Year Est. Return
28.69%
This Fund
S&P 500
This Quarter
Est. Return
+9.12%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$21.6B
AUM Growth
+$1.94B
(+9.9%)
Cap. Flow
+$436M
Cap. Flow
% of AUM
2.02%
Top 10 Holdings %
Top 10 Hldgs %
28.47%
Holding
769
New
76
Increased
265
Reduced
236
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$130M |
| 2 |
UnitedHealth
UNH
|
+$111M |
| 3 |
Intuitive Surgical
ISRG
|
+$86.1M |
| 4 |
GE Aerospace
GE
|
+$76.1M |
| 5 |
Novartis
NVS
|
+$67.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$238M |
| 2 |
Microsoft
MSFT
|
+$83.2M |
| 3 |
Meta Platforms (Facebook)
META
|
+$71.8M |
| 4 |
LTHM
Livent Corporation
LTHM
|
+$66.7M |
| 5 |
Canadian Solar
CSIQ
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.12% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 9.5% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Communication Services | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTVE
651
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $169K | ﹤0.01% |
22,275
-5,625
| -20% | -$42.9K |
|
|
VOXX
652
DELISTED
VOXX International Corporation Class A
VOXX
| $165K | ﹤0.01% |
13,200
| – | – |
|
653
Universal Electronics
UEIC
$57.8M
| $159K | ﹤0.01% |
16,568
+5,400
| +48% | +$50K |
|
654
Evolution Petroleum
EPM
$132M
| $146K | ﹤0.01% |
18,143
-9,206
| -34% | -$68.1K |
|
|
OSG
655
DELISTED
Overseas Shipholding Group Inc.
OSG
| $138K | ﹤0.01% |
33,213
+18,613
| +127% | +$71.9K |
|
656
Unilever
UL
$137B
| $135K | ﹤0.01% |
2,300
-4
| -0.2% | -$238 |
|
657
Quad
QUAD
$536M
| $132K | ﹤0.01% |
35,200
| – | – |
|
658
Vitamin Cottage Natural Grocers
NGVC
$739M
| $129K | ﹤0.01% |
10,500
| – | – |
|
659
SelectQuote
SLQT
$132M
| $124K | ﹤0.01% |
63,467
+22,867
| +56% | +$38.5K |
|
660
EverQuote
EVER
$892M
| $120K | ﹤0.01% |
18,500
| – | – |
|
661
Douglas Elliman
DOUG
$154M
| $119K | ﹤0.01% |
53,760
+14,805
| +38% | +$40.6K |
|
662
Cato Corp
CATO
$68.3M
| $115K | ﹤0.01% |
14,320
| – | – |
|
663
Lincoln Educational Services
LINC
$1.33B
| $74.8K | ﹤0.01% |
11,100
| – | – |
|
664
Amneal Pharmaceuticals
AMRX
$5.85B
| $71.6K | ﹤0.01% |
23,100
| – | – |
|
665
Alibaba
BABA
$293B
| $70.3K | ﹤0.01% |
844
+15
| +2% | +$1.31K |
|
|
CURO
666
DELISTED
CURO Group Holdings Corp.
CURO
| $68K | ﹤0.01% |
50,371
| – | – |
|
667
DHI Group
DHX
$182M
| $65.9K | ﹤0.01% |
17,200
| – | – |
|
668
Ambev
ABEV
$48.1B
| $64.2K | ﹤0.01% |
20,200
| – | – |
|
|
AZRE
669
DELISTED
Azure Power Global Limited
AZRE
| $60.5K | ﹤0.01% |
34,200
-5,300
| -13% | -$11.6K |
|
670
Five Point Holdings
FPH
$376M
| $49.7K | ﹤0.01% |
17,200
-6,881
| -29% | -$16.5K |
|
671
Community Health Systems
CYH
$393M
| $46.2K | ﹤0.01% |
10,500
-9,900
| -49% | -$42.1K |
|
672
LifeVantage
LFVN
$81.1M
| $45.3K | ﹤0.01% |
10,414
| – | – |
|
|
NGM
673
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $37.3K | ﹤0.01% |
14,397
-11,903
| -45% | -$42.5K |
|
674
Nuvation Bio
NUVB
$2.2B
| $21.2K | ﹤0.01% |
11,800
| – | – |
|
|
NBIS
675
Nebius Group N.V.
NBIS
$48.3B
| $20.8K | ﹤0.01% |
109,700
| – | – |
|
Similar funds
HF
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2023 Portfolio in Review
As of Q2 2023, Grantham, Mayo, Van Otterloo & Co (GMO) held 769 positions worth $21.6B, up 9.9% from $19.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2023 filing shows 76 new, 265 increased, 236 reduced and 94 closed positions. Its largest new stake was GE Aerospace: 940,083 shares worth $82.4M. The largest sale was Medtronic, an estimated $238M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q2 2023 buy was GE Aerospace: 940,083 shares worth $82.4M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to Abbott in Q2 2023, an estimated $130M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q2 2023 reduction was Medtronic, cutting an estimated $238M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Occidental Petroleum in Q2 2023, selling an estimated $37.1M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 28% of its $21.6B portfolio in Q2 2023.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 76 new positions and closed 94 in Q2 2023.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 9.9% quarter-over-quarter to $21.6B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2023, filed 14 Aug 2023.